(Q26749317)

4

object named as

Gill Worthy

0 references

author name string

Carol A Forbes

1

0 references

Ruben G W Quek

2

0 references

Sohan Deshpande

3

0 references

Robert Wolff

5

0 references

Lisa Stirk

6

0 references

Shravanthi R Gandra

8

0 references

Stephen Djedjos

9

0 references

Nathan D Wong

Lipids in Health and Disease

10

0 references

language of work or name

English

0 references

publication date

17 May 2016

2 references

17 June 2019

19 November 2019

2 references

17 June 2019

19 November 2019

15

0 references

issue

1

0 references

page(s)

95

0 references

copyright license

Creative Commons Attribution 4.0 International

2 references

Europe PubMed Central

17 June 2019

https://scigraph.springernature.com/pub.10.1186/s12944-016-0258-8

Europe PubMed Central

19 November 2019

0 references

0 references

cites work

Lipoprotein(a) as a cardiovascular risk factor: current status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein (a) and stroke: a meta-analysis of observational studies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a) mass: a massively misunderstood metric

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Variations in ischemic heart disease burden by age, country, and income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a), cardiovascular disease, and contemporary management.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a) for risk assessment in patients with established coronary artery disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Comparison of morphological features of carotid arteries atherosclerotic plaques with clinical-instrumental data in symptomatic and asymptomatic patients with severe carotid atherosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Assessing bias in studies of prognostic factors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Association between baseline lipoprotein (a) levels and restenosis after coronary stenting: meta-analysis of 9 cohort studies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Genetic associations with valvular calcification and aortic stenosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Large-scale association analysis identifies new risk loci for coronary artery disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Dyslipidemias in the prevention of cardiovascular disease: risks and causality.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

High Lipoprotein(a) Levels are Associated With Long-Term Adverse Outcomes in Acute Myocardial Infarction Patients in High Killip Classes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lp(a) lipoprotein, vascular disease, and mortality in the elderly

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Association of transient ischemic attack/stroke symptoms assessed by standardized questionnaire and algorithm with cerebrovascular risk factors and carotid artery wall thickness. The ARIC Study, 1987-1989.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Metabolic risk factors for stroke and transient ischemic attacks in middle-aged men: a community-based study with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease. The Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Mild elevation of fasting plasma glucose is a strong risk factor for postoperative complications in gastric bypass patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Correlates of vascular access occlusion in hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Usefulness of Lipoprotein (a) for predicting progression of non-culprit coronary lesions after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Impact of high lipoprotein(a) levels on in-stent restenosis and long-term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug-eluting stents in Asian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Lipoprotein(a), Interleukin-10, C-Reactive Protein, and 8-Year Outcome After Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Mechanisms of Lipoprotein(a) Pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12944-016-0258-8

Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4869344

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

28 November 2018

1 reference

12 December 2020

Elevated Lipoprotein(a) has Incremental Prognostic Value in Type 2 Diabetic Patients with Symptomatic Coronary Artery Disease

1 reference

12 December 2020

Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes

1 reference

12 December 2020

Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients

1 reference

12 December 2020

Lipoprotein(a) levels in black and white children and adolescents with IDDM

1 reference

12 December 2020

A prospective study of the role of lipoprotein(a) in the pathogenesis of unstable angina

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study

1 reference

12 December 2020

Lipoprotein(a): there's life in the old dog yet

1 reference

12 December 2020

Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis

1 reference

12 December 2020

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

1 reference

12 December 2020

Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies

1 reference

12 December 2020

Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population

1 reference

12 December 2020

Extreme lipoprotein(a) levels and improved cardiovascular risk prediction

1 reference

12 December 2020

Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis

1 reference

12 December 2020

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

1 reference

12 December 2020

Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study

1 reference

12 December 2020

Phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohort

1 reference

12 December 2020

Lipoprotein(a) and coronary thrombosis and restenosis after stent placement

1 reference

12 December 2020

Lipoprotein(a) and cardiovascular disease in ethnic Chinese: the Chin-Shan Community Cardiovascular Cohort Study

1 reference

12 December 2020

Serum triglyceride: a possible risk factor for ruptured abdominal aortic aneurysm

1 reference

12 December 2020

Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men

1 reference

12 December 2020

10.1186/S12944-016-0258-8

Identifiers

DOI

1 reference

Dimensions Publication ID

1604489

1046881752

0 references

1604489

1 reference

1 reference

1 reference